Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 104-111

Informa Healthcare

Access to resources Recommend Favorite

Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and France

By Clark W. H.   Hassoun D.   Gemzell-Danielsson K.   Fiala C.   Winikoff B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 3, 2005-09 ,pp. : 184-191

Informa Healthcare

Access to resources Recommend Favorite

An overview of medical abortion using low-dose mifepristone and misoprostol

By Mathur Manisha   Ashok Premila  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 371-378

Informa Healthcare

Access to resources Recommend Favorite

Review of the literature on patient satisfaction with early medical abortion using mifepristone and misoprostol

By Swica Yael   Raghavan Sheila   Bracken Hillary   Dabash Rasha   Winikoff Beverly  

Expert Review of Obstretrics and Gynecology, Vol. 6, Iss. 4, 2011-07 ,pp. : 451-468

Informa Healthcare

Access to resources Recommend Favorite

Experience and Acceptability of Medical Abortion with Mifepristone and Misoprostol Among U.S. Women

By Beckman L.J.   Harvey S.M.  

Women's Health Issues, Vol. 7, Iss. 4, 1997-07 ,pp. : 253-262

Elsevier

Access to resources Recommend Favorite